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Yukiyasu Okamura, MD, PhD, Kiyoshi Ishigure, MD, PhD, Mitsuro Kanda, MD, PhD, FACS,
Shin Takeda, MD, PhD, Satoshi Morita, PhD, Akimasa Nakao, MD, PhD, FACS, and
Yasuhiro Kodera, MD, PhD, FACS
Abstract: The usefulness of enteral nutrition via a nasointestinal tube
for patients who develop postoperative pancreatic fistula (POPF) after
miscellaneous pancreatectomy procedures has been reported. However,
no clear evidence regarding whether oral intake is beneficial or harmful
during management of POPF after distal pancreatectomy (DP) is
currently available.
To investigate the effects of oral food intake on the healing process
of POPF after DP.
Multi-institutional randomized controlled trial in Nagoya University
Hospital and 4 affiliated hospitals.
Patients who developed POPF were randomly assigned to the dietary
intake (DI) group (n¼ 15) or the fasted group (no dietary intake [NDI]
group) (n¼ 15). The primary endpoint was the length of drain placement.
No significant differences were found in the length of drain place-
ment between the DI and NDI groups (12 [6–58] and 12 [7–112] days,
respectively; P¼ 0.786). POPF progressed to a clinically relevant status
(grade B/C) in 5 patients in the DI group and 4 patients in the NDI group
(P¼ 0.690). POPF-related intra-abdominal hemorrhage was found in 1
patient in the NDI group but in no patients in the DI group (P¼ 0.309).
There were no significant differences in POPF-related intra-abdominal
hemorrhage, the incidence of other complications, or the length of the
postoperative hospital stay between the 2 groups.
Food intake did not aggravate POPF and did not prolong drain
placement or hospital stay after DP. There may be no need to avoid
oral DI in patients with POPF.
(Medicine 94(52):e2398)
Abbreviations: CT = computed tomography, DI = dietary intake,
DP = distal pancreatectomy, ISGPF = International Study Group on
Pancreatic Fistula, NDI = no dietary intake, POPF = postoperative
pancreatic fistula, RCT = randomized controlled trial.
INTRODUCTION
D istal pancreatectomy (DP) is a standard procedure forbenign and malignant neoplasms of the distal pancreas.
Despite recent advances in surgical techniques and periopera-
tive management, the reported incidence of postoperative pan-
creatic fistula (POPF) after DP ranges from 10% to 40%.1–4 The
main reported risk factors for POPF are a high body mass index,
history of diabetes, large-volume pancreatic remnant, extended
lymphadenectomy, longer operative time, and a thick pancreatic
stump after staple closure.4–8 In an effort to avoid this intract-
able complication, numerous techniques and tools including
staple closure, suture ligation with mattress stitches, pancrea-
ticoenteric anastomosis, fibrin glue, and ultrasonic devices have
been proposed and investigated.3,4,9–16 However, there is cur-
rently no universally accepted effective technique.
Food intake releases gastrointestinal hormones such as
secretin and cholecystokinin and promotes the secretion of
digestive juices, including pancreatic juice.17 Fasting is some-
times considered necessary to suppress the secretion of pancreatic
juice in patients with POPF, and the necessity of ‘‘nothing by
mouth’’ (nil per os, NPO) was also described in the International
Study Group on Pancreatic Fistula (ISGPF) criteria.18 However,
fasting management requires total parenteral nutrition and leads
to metabolic adverse events, including negative functional and
morphological changes of the gastrointestinal mucosa and pan-
creas.19 Klek et al20 performed a randomized controlled trial
(RCT) comparing fasting management and enteral nutrition via a
nasointestinal tube in patientswithPOPFand reported that enteral
nutrition was associated with significantly shorter times to POPF
closure. In their cohort, however, miscellaneous operative pro-
cedureswere performed, including pancreatoduodenectomy,DP,
necrosectomy, and gastrectomy. Our recent RCT compared oral
dietary intake (DI) and fasting in patients with POPF after
pancreatoduodenectomy, showing that food intake did not aggra-
vate POPF and did not prolong the length of drain placement or
hospital stay.21 However, no clear evidence regarding whether
oral intake can be tolerated while POPF exists in patients under-
going DP is currently available.
In this study, we focused only on DP as the operative
method. Amulti-institutional RCTwas conducted to investigate
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the effects of oral intake on the healing process by comparing
the fasted group (no dietary intake [NDI] group) and the DI
group during the management of POPF.
METHODS
Trial Design
This study was performed in Nagoya University Hospital
and 4 affiliated hospitals, which performed at least 20 pancreatic
resections per year. The study protocol was registered at the
UniversityHospitalMedical InformationNetwork Clinical Trials
Registry (UMIN000003940). A uniform protocol was submitted
to and approved by the institutional review boards at each
institution. The study was carried out in accordance with the
international ethical recommendations described in the Declara-
tion of Helsinki. Written informed consent was obtained from all
patients. The coordinating center trained the research personnel at
each institution before enrollment; therefore, operative pro-
cedures and intraoperative and postoperative management were
unified in all institutions. All supporting datawere collected from
each institution using a secure electronic data capture system.
DP was performed in patients with disease of the pancrea-
tic body and tail region from July 2010 to September 2012. The
eligibility criteria were an age of 20 years and a diagnosis of
POPF according to the ISGPF definition. The exclusion criteria
were regular use of medication that might affect the healing
process (eg, adrenal corticosteroids), current hemodialysis treat-
ment, and past or current severe cardiovascular, pulmonary,
renal, or liver dysfunction.
Surgical Technique
Operative procedures were identical throughout the study
period, as previously reported.22–25 In open DP cases, the
pancreas was transected with a scalpel, and the main pancreatic
duct on the cut surface was closed with 5–0 polypropylene in a
continuous pattern. Bleeding from the pancreatic parenchyma
was controlled with a combination of cautery and suture
ligation. In laparoscopic DP cases, straight or rotated endo-
scopic linear staplers of various sizes (staple height, 3.5–
4.2mm) were used, depending on the thickness or hardness
of the pancreas. A silastic flexible drain (Blake1; Ethicon, Inc.,
Somerville, NJ) was routinely placed adjacent to the pancreatic
remnant and connected to a continuous-suction device (J-Vac
Suction Reservoir; Johnson & Johnson, Tokyo, Japan).
Patient characteristics and perioperative and postoperative
parameters were reviewed for the following clinical variables:
age, sex, histologic diagnosis, comorbidities, preoperative body
mass index,26 preoperative serum albumin level, total lympho-
cyte count, hemoglobin concentration, platelet count, total
bilirubin and cholinesterase levels, operative method, operative
time, intraoperative blood loss, blood transfusion, drainage
output volume and serum level of nutritional factors including
albumin, prealbumin, transferrin, and retinol-binding protein as
well as the total lymphocyte count on days 5, 12, and 21.27 The
estimated pancreatic parenchymal remnant volume was
measured on transverse sections of preoperative multiphasic
computed tomography (CT), as previously reported.7,28 Briefly,
serial transverse CT images were obtained at 2.0-mm intervals,
the borders of the estimated pancreatic parenchymal remnant
and the estimated transection line were outlined on every CT
slice, and the corresponding volume was calculated as the
product of the pancreatic parenchymal area times the slice
thickness.
Randomization
The amylase level of the drainage fluid was measured on
postoperative days 1, 3, and 5 and every other day thereafter
until drain removal. POPF was defined according to the ISGPF
criteria: that is, when the amylase level of the drainage fluid on
postoperative day 5 was more than 3 times the upper limit of the
normal serum level.18 The amylase level of the drainage fluid
was confirmed on postoperative day 5 for all patients, including
patients without POPF on postoperative day 3. After diagnosis
of POPF, patients were randomized in a 1:1 ratio to either the DI
or NDI group on postoperative day 5. A computer-generated
central randomization schema was implemented in an auto-
mated web system. No blocking or stratification was used.
Postoperative Management
After randomization, patients in the NDI group were fasted
until drain removal. Parenteral nutrition was commenced after
surgery via a central venous catheter. Unicaliq N (Terumo,
Tokyo, Japan), a 1600-kcal all-in-one admixture containing
vitamins, electrolytes, and trace elements, was administered
continuously for 24 h/d. In the DI group, food intake was started
on postoperative day 6. Rice porridge of 750 kcal (38 g protein,
30 g fat) was given for the first 3 days, soft rice of 1300 kcal
(63 g protein, 40 g fat) was given for the next 4 days, and a solid
diet of 1650 kcal (78 g protein, 45 g fat) was given thereafter.
Actual oral caloric intake was measured at every meal. Par-
enteral nutrition was replenished daily depending on the DI of
each individual patient, and the total calorie level was controlled
to be equivalent to that of the NDI group. Patients in both groups
were allowed to drink water. All patients received postoperative
proton-pump inhibitors. No patients received postoperative
somatostatin analogues or perioperative radiotherapy.
FIGURE 1. CONSORT diagram for the present trial.
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Study Endpoints
The primary endpoint was the length of drain placement.
The criteria for drain removal were a drain output volume of
<20mL/d, a drainage fluid amylase level of<3 times the upper
limit of the normal serum level, clear drainage fluid, and no
bacterial contamination.
One of the secondary endpoints was the incidence of
clinically relevant POPF (ISGPF grade B/C). POPF was sub-
classified into grade A (requiring little change in clinical
management or deviation from the normal clinical pathway),
grade B (requiring a change in clinical management or adjust-
ment of the clinical pathway), and grade C (requiring a major
change in clinical management or deviation from the normal
clinical pathway).18 A POPF of grade B or C was considered
clinically significant. The other secondary endpoints were the
incidence of POPF-related intra-abdominal hemorrhage, post-
operative mortality of any cause within 60 days after surgery,
the length of the postoperative hospital stay, and the rates of
postoperative complications other than POPF. POPF-related
intra-abdominal hemorrhage and delayed gastric emptying were
defined according to the criteria outlined by the International
Study Group on Pancreatic Surgery.29,30 The length of the
postoperative hospital stay was defined as the number of
days from the day of surgery through the day of hospital
discharge.
Statistics
Two biostatisticians (KM and SM) were responsible for
statistical analysis. Based on preliminary unpublished retro-
spective data from the authors’ department, it was assumed that
the length of drain placement in the NDI group was 10.0 2.5
days (mean standard deviation) and that DI would prolong
drain placement for 3 days in patients with POPF. Calculations
usingWilcoxon test showed that 13 patients should be allocated
to each of the 2 arms to achieve a power of 80% and significance
level of 0.05 to evaluate the superiority of fasting. Allowing for
an estimated dropout rate of approximately 10% in each group,
enrollment of 30 patients was considered necessary to meet the
primary endpoint of this study.
Differences in the numerical data between the 2 groupswere
examined using the chi-squared test or Fisher’s exact test when n
< 5. Differences in quantitative variables between the 2 groups
were evaluated usingStudent t test or theMann–WhitneyU test if
the distribution was abnormal. Risk factors for progression to
clinically relevant POPF were evaluated using binomial logistic
regression analysis. Statistical analysis was performed using
TABLE 1. Clinical Characteristics of the Enrolled Patients and Perioperative Details
DI Group (n¼ 15) NDI Group (n¼ 15) P
Age, y

67.5 (56–82) 62 (43–78) 0.197
Sex, male/female 9/6 10/5 0.705
Disease 0.465
Pancreatic cancer 7 11
IPMN 3 1
Endocrine neoplasm 1 1
Others 4 2
Comorbidity
Diabetes mellitus 2 5 0.195
Cardiovascular disease 1 2 0.543
Pulmonary disease 1 1 1.000
Hypertension 2 0 0.143
Peptic ulcer 2 0 0.143
Preoperative body mass index

22.3 (16.3–33.6) 23.6 (16.7–26.3) 0.724
Preoperative chemotherapy 0 0 1.000
Preoperative blood test
Albumin, g/dLy 4.1 0.3 3.9 0.4 0.196
Total lymphocyte count, per mm3y 1770 586 1640 856 0.315
Hemoglobin, g/dLy 13.2 1.6 13.1 1.3 0.967
Platelet count, 104/mm3y 19.7 4.4 20.5 3.9 0.647
Total bilirubin, mg/dLy 0.5 0.2 0.7 0.3 0.055
Cholinesterase, IU/Ly 308 60 291 74 0.570
Operative method 0.543
Open DP with splenectomy 13 12
Open spleen-preserving DP 1 2
Laparoscopic DP with splenectomy 1 1
Concomitant resection of other organs 1 2 0.543
Operative time, min

205 (91–628) 285 (176–421) 0.236
Intraoperative blood loss, mL

448 (50–1604) 558 (123–1377) 0.813
Intraoperative blood transfusion 2 2 1.000
DI¼ dietary intake, DP¼ distal pancreatectomy, IPMN¼ intraductal papillary mucinous neoplasm, NDI¼ no dietary intake.
Values are median (range).
yMean standard deviation.
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JMP1 version 10 software (SAS Institute, Inc., Cary, NC). A P
value of <0.05 was considered statistically significant.
RESULTS
In total, 81 patients underwent DP (Figure 1). Thirty
patients with POPF after DP were randomized to the DI group
(food intake from postoperative day 6) and the NDI group
(no food intake until drain removal) from July 10, 2010 to
September 30, 2012. No patient withdrew consent after
randomization.
Patients’ Characteristics and Perioperative Status
The patients’ characteristics, preoperative status, and pre-
operative blood test results are summarized in Table 1. The
primary disease for which surgery was performed was similar
in the 2 groups. There were no significant differences in the other
background data between the 2 groups. The operative time, blood
loss, and the incidenceof intraoperative blood transfusionwere not
significantly different between the 2 groups. The median post-
operative fasting period was 15 days in the NDI group (Table 2).
Themean actual caloric intake from the diet on postoperative days
7, 10, and 14 was 579, 813, and 1060 kcal, respectively.
Postoperative Changes in Serum Nutritional
Indicators
The serumalbumin level, total lymphocyte count, and levels
of rapid-turnover proteins, including prealbumin, transferrin, and
retinol-binding protein, were evaluated preoperatively and on
postoperative days 5, 12, and 21. All parameters were lowest on
postoperative day 5 in both groups and subsequently recovered;
there were no significant differences between the 2 groups
(Figure 2).
Amylase Level and Drainage Fluid Output
Volume
Figure 3A and B shows the amylase level and peripan-
creatic drainage fluid output volume. The median postoperative
amylase level of the drainage fluid was statistically similar
between the DI and NDI groups (postoperative day 1, 6715 vs
7989 IU/L, P¼ 0.513; day 3, 1991.5 vs 2475.0 IU/L, P¼ 0.396;
day 5, 451 vs 903 IU/L, P¼ 0.295; and day 7, 513 vs 750 IU/L,
P¼ 0.090).
Comparison of Clinically Relevant POPF and
Other Complications
Postoperative complications were compared between the
2 groups to clarify whether food intake influenced their inci-
dence (Table 2). POPF progressed to a clinically relevant status
(grade B/C) in 5 patients in the DI group and in 4 patients in the
NDI group (P¼ 0.690). No significant differences were found
in the length of drain placement between theDI andNDI groups
(12 [6–58] vs 12 [7–112] days; P¼ 0.786); the cumulative
incidence rates were also statistically equivalent between the
2 groups (Figure 3C). A drain was reinserted on the day after
TABLE 2. Postoperative Complications
DI Group (n¼ 15) NDI Group (n¼ 15) P
POPF 0.461
Grade A 10 11
Grade B 5 3
Grade C 0 1
Clinically relevant POPF (grade B/C) 5 4 0.690
POPF-related hemorrhage 0 1 0.309
Length of drain placement, d

12 (6–58) 12 (7–112) 0.786
Delayed gastric emptying 0 1 0.309
Intra-abdominal abscess 3 3 1.000
Biliary leakage 0 0 1.000
Ileus 0 1 0.309
Central venous catheter infection 1 4 0.142
Wound infection 1 1 1.000
Postoperative fasting period, d

5 (5–5) 15 (7–46) <0.001
Caloric intake from the diet (kcal/d, mean)
POD 7 580 N/A
POD 10 810 N/A
POD 14 1060 N/A
Drainage output volume, mL

POD 1 46 (5–120) 56 (14–250) 0.430
POD 3 10 (1–60) 10 (1–270) 0.181
POD 5 4 (1–60) 5 (1–50) 0.620
POD 7 5 (1–87) 5 (1–35) 0.836
Postoperative hospital stay, d

24 (12–91) 26 (15–119) 0.418
Reoperation 0 0 1.000
Readmission 2 0 0.143
Mortality 0 0 1.000
Median total hospital cost, Japanese yen 1568,950 1529,100 0.901
DI¼ dietary intake, N/A¼ not applicable, NDI¼ no dietary intake, POD¼ postoperative day, POPF¼ postoperative pancreatic fistula.
Values are median (range).
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the removal of the original drain in 1 case in the NDI group. In
this case, the duration of drain placement was calculated from
the insertion of the initial drain until the removal of the second
drain. There were no significant differences in POPF-related
intra-abdominal hemorrhage (P¼ 0.309), the incidence of
other complications, or the length of the postoperative hospital
stay (P¼ 0.418) between the 2 groups. The incidence of central
venous catheter infection tended to be higher in the NDI group,
although the difference between the 2 groups was not signifi-
cant (P¼ 0.142). No patients in either group died of any cause
within 60 days after surgery. No important harms or unintended
effects were found in each group. The median total hospital
costs were similar between the 2 groups (¥1568,950 in
the DI group vs ¥1529,100 in the NDI group: P¼ 0.901;
Table 2).
Predictive Factors for Progression to Clinically
Relevant POPF
The factors predicting clinically relevant POPF (grade B/
C) are shown in Table 3. Binomial logistic regression analysis
showed that an estimated pancreatic parenchymal remnant
volume was an independent predictive factor of clinically
relevant POPF (odds ratio, 4.16; 95% confidence interval,
2.01–9.53; P¼ 0.026). DI after postoperative day 5 was not
significantly associated with clinical progression of POPF.
DISCUSSION
Whether regular DI affects POPF and whether DI is
possible when POPF occurs are issues of particular interest
to clinicians. Klek et al20 reported that enteral nutrition rather
than parenteral nutrition with fasting was associated with
significantly higher POPF closure rates and shorter times to
POPF closure. In our recent study, oral food intake did not
exacerbate POPF and did not prolong hospital stay in patients
undergoing pancreatoduodenectomy.21 However, no previous
reports have fully addressed the impact of diet on POPF
after DP.
In the present study, there was no significant difference in
the prerandomization status between the DI and NDI groups,
including the incidence of comorbidities, results of preoperative
blood tests, preoperative body mass index, and output volume
and amylase level of the peripancreatic drainage fluid. Both
groups were sufficiently uniform to minimize potential bias
related to the differences in baseline characteristics. After the
initiation of food intake, no significant differences were found
in the length of drain placement, incidence of clinically relevant
POPF, or incidence of other postoperative complications,
including ileus and POPF-related intra-abdominal hemorrhage
(ISGPF grade C). Multivariate analysis showed that an esti-
mated remnant pancreatic parenchymal volume was an inde-
pendent predictive factor of progression to clinically relevant
FIGURE 2. Preoperative and 5-, 12-, and 21-day postoperative (A) serum albumin level, (B) total lymphocyte count, and (C) levels of
rapid-turnover proteins including prealbumin, transferrin, and retinol-binding protein. There were no significant differences between the
DI and NDI groups at any time points. DI¼dietary intake, NDI¼no dietary intake.
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POPF. DI after postoperative day 5, however, was not signifi-
cantly correlated with clinical progression of POPF.
Cholecystokinin is synthesized by I-cells in the mucosal
epithelium of the jejunum and is secreted into the duodenum
and upper jejunum.31 Secretin is produced in the S-cells of the
duodenum. The results of both of these gastrointestinal hor-
mones is promoted by DI, resulting in the stimulation of
pancreatic exocrine secretion; however, the control system of
pancreatic exocrine secretion has still not been fully eluci-
dated.32 Enteral nutrition reportedly inhibits the exocrine pan-
creas by negative feedback involving a variety of hormones.33
Secretion of pancreatic juice may not be significantly affected
by conditions such as food volume and fat content of the diet. In
the present study, patients who underwent DP were able to take
only 65% to 75% of the meals that were provided, which might
have minimized the influence of the diet on POPF. Enteral
nutrition possibly has benefits in terms of compensating for the
influence of increased pancreatic juice secretion, because there
is a general agreement that enteral nutrition has more favorable
impacts on the body, such as promotion of wound healing and
minimization of exuberant granulation tissue, than does
parenteral nutrition.34 Previous RCTs and meta-analyses have
also revealed that total enteral nutritional support is associated
with lower mortality, fewer infectious complications, and
decreased organ failure than is parenteral nutritional support
in patients with acute pancreatitis.35,36
Klek et al reported that the median time to POPF closure
was 37.5 and 43.5 days in the enteral and parenteral nutrition
groups, respectively. These times to closure differed greatly
from those in the present study (12 days in both groups). This
difference may have occurred because Klek et al included
patients undergoing various pancreatectomy procedures. Inter-
estingly, no significant differences were found in nutritional
status indicators after the initiation of food intake in the present
study (eg, albumin level total lymphocyte count, and levels of
rapid-turnover proteins including prealbumin, transferrin, and
retinol-binding protein). In the DI group, the mean actual
caloric intake from the diet on postoperative days 7, 10, and
14 was 580, 810, and 1060 kcal, respectively. Thus, the DI just
after DP, an invasive surgical procedure, seemed to be insuffi-
cient for these adult patients. Additionally, the speed of POPF
healing was similar between the DI and NDI groups in the
FIGURE 3. (A) Amylase level in the drainage fluid. No significant differencewas found in themedian amylase level on postoperative day 1,
3, 5, or 7 between the DI and NDI groups (6715 vs 7989 IU/L, 1991.5 vs 2475.0 IU/L, 451 vs 903 IU/L, and 513 vs 750 IU/L, respectively;
P¼0.513, 0.396, 0.295, and 0.090). (B) Drainage fluid output volume. No significant difference was found on postoperative day 1, 3, 5,
or 7 between the DI and NDI groups (46 vs 56mL, 10 vs 10mL, 4 vs 5mL, and 5 vs 5mL, respectively; P¼0.704, 0.181, 0.612, and
0.836). (C) Cumulative incidence rate of POPF after distal pancreatectomy. There was no significant difference between the 2 groups
(P¼0.945, log-rank test). DI¼dietary intake, NDI¼no dietary intake, POPF¼postoperative pancreatic fistula.
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present study; this differed from the results of the study by Klek
et al, in which enteral nutrition was administered at 40 kcal/kg
body weight.
The present study is not powered to show that oral food
intake does not prolong time to POPF closure compared with
fasting because the 2 groups exhibited no difference, although it
was assumed that a difference of 3 days would be present. A
type II error may exist, and this is the major limitation of the
study. Statistically speaking, the results of this study only reject
the hypothesis that oral food intake prolongs the duration of
drain placement. Further investigation with an adequate sample
size is necessary to confirm the noninferiority of management
with oral food intake.
In conclusion, food intake did not aggravate POPF and did
not prolong drain placement or hospital stay after DP. Although
not confirmative, the present study implies that there is no need
to avoid DI in patients with POPF. Considering also the study by
Klek et al, fasting is deemed to be of little benefit.
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